1. Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health care

   • Srdjan M. Stefanovic
   • Slobodan M. Jankovic

   Clinical Trial 14 May 2011 Pages: 1091 - 1101

2. The impact of high-dose statin therapy on transendothelial neutrophil migration and serum cholesterol levels in healthy male volunteers

   • Aisling Kinsella
   • Adnan Raza
   • R. W. Watson

   Clinical Trial 08 June 2011 Pages: 1103 - 1108

   

3. The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia

   • Robert Krysiak
   • Anna Gdula-Dymek
   • Boguslaw Okopien

   Pharmacodynamics Open access 01 June 2011 Pages: 1109 - 1117

4. Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients

   • Nassr Eldin M. A. Shrif
   • Hong-Hee Won
   • Jong-Won Kim

   Pharmacogenetics 18 May 2011 Pages: 1119 - 1130

   

5. A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C)

   • Charlotte Brasch-Andersen
   • Malik U. Møller
   • Søren H. Sindrup

   Pharmacogenetics 26 May 2011 Pages: 1131 - 1137

6. Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method

   • Eleni Aklillu
   • Sabina Mugusi
   • Johanna Weiss

   Pharmacogenetics 01 June 2011 Pages: 1139 - 1145

   

7. BCHE and CYP2D6 genetic variation in Alzheimer’s disease patients treated with cholinesterase inhibitors

   • Caterina Chianella
   • Daniela Gragnaniello
   • Silvia Fuselli

   Pharmacogenetics 01 June 2011 Pages: 1147 - 1157

   

8. No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid

   • Xiaoqiang Xiang
   • Juha Vakkilainen
   • Mikko Niemi

   Pharmacogenetics 08 June 2011 Pages: 1159 - 1167

   

9. Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic

   • Jane Skov
   • Else-Marie Bladbjerg
   • Jørgen Jespersen

   Pharmacoepidemiology and Prescription 12 May 2011 Pages: 1169 - 1174

10. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals

    • Paul Gallagher
    • Pierre Olivier Lang
    • Denis O’Mahony

    Pharmacoepidemiology and Prescription 17 May 2011 Pages: 1175 - 1188

    

11. Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database

    • Nadège Rouve
    • Haleh Bagheri
    • the French Association of Regional PharmacoVigilance Centres

    Pharmacoepidemiology and Prescription 08 June 2011 Pages: 1189 - 1198

12. Anything new in EU pharmacovigilance?

    • Silvio Garattini
    • Vittorio Bertele’

    Point of View 04 May 2011 Pages: 1199 - 1200

13. Looking at EU pharmacovigilance

    • Andrew Herxheimer

    Open Commentary 13 July 2011 Pages: 1201 - 1202

14. A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol

    • Sonia Radice
    • Anna Milanesi
    • Emilio Clementi

    Letter to the Editors 03 June 2011 Pages: 1203 - 1204